Lv61
2280 积分 2022-06-14 加入
GFH018 and toripalimab combination therapy for previously treated recurrent or metastatic nasopharyngeal carcinoma: Results from a phase 1b/2 study
4天前
已完结
Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer
4天前
已完结
Sotorasib for previously treated colorectal cancers with KRASG12C mutation (CodeBreaK100): a prespecified analysis of a single-arm, phase 2 trial
1个月前
已完结
Strategies to therapeutically modulate cytokine action
2个月前
已完结
Strategies for targeting cytokines in inflammatory bowel disease
2个月前
已完结
IL-33/ST2 axis in autoimmune disease
2个月前
已完结
Inavolisib-Based Therapy in PIK3CA -Mutated Advanced Breast Cancer
2个月前
已完结
KRAS mutated colorectal cancers with or without PIK3CA mutations: Clinical and molecular profiles inform current and future therapeutics
2个月前
已完结
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
3个月前
已完结
Revolutionizing NSCLC Treatment: Unleashing the Potential of IBI351 and Its Critical Care Impact
3个月前
已完结
皖公网安备34019202002308
